Estrogen receptor inhibitor TAK-875, Purity ≥98%

Cat. No.: X24-06-ZQ784

Estrogen receptor inhibitor TAK-875, Purity ≥98%

Synonym: 1000413-72-8; Estrogen receptor inhibitor; TAK875

  • MDL: MFCD18251445
  • CAS Number: 1000413-72-8
  • Compound CID: 24857286
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
TAK-875, soluble in DMSO and insoluble in ethanol and water, prevents the growth of cancer cells that depend on estrogen for proliferation.
Molecular Weight
524.6
Molecular Formula
C29H32O7S
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 92 mg/mL (172.4 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
TAK-875 is investigated as an estrogen receptor inhibitor to evaluate its potential effects on glucose metabolism and type 2 diabetes.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0